SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Cheng-long Xie, Jia-Lin Pan, Wen-Wen Wang, Yu Zhang, Su-fang Zhang, Jing Gan, Zhen-Guo Liu, The association between the LRRK2 G2385R variant and the risk of Parkinson’s disease: a meta-analysis based on 23 case–control studies, Neurological Sciences, 2014, 35, 10, 1495

    CrossRef

  2. 2
    Chao Gao, Hao Pang, Xiao-Guang Luo, Yan Ren, Hong Shang, Zhi-Yi He, LRRK2 G2385R variant carriers of female Parkinson’s disease are more susceptible to motor fluctuation, Journal of Neurology, 2013, 260, 11, 2884

    CrossRef

  3. 3
    Yishu Zhou, Xiaoguang Luo, Fengrui Li, Xiaofei Tian, Lanhui Zhu, Yichun Yang, Yan Ren, Hao Pang, Association of Parkinson’s disease with six single nucleotide polymorphisms located in four PARK genes in the northern Han Chinese population, Journal of Clinical Neuroscience, 2012, 19, 7, 1011

    CrossRef

  4. 4
    Kumar M Prakash, Eng-King Tan, Development of Parkinson’s disease biomarkers, Expert Review of Neurotherapeutics, 2010, 10, 12, 1811

    CrossRef

  5. 5
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  6. 6
    Jong-Min Kim, Jee-Young Lee, Hee Jin Kim, Ji Seon Kim, Eun-Soon Shin, Jin-Hwan Cho, Sung Sup Park, Beom S. Jeon, The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population, Parkinsonism & Related Disorders, 2010, 16, 2, 85

    CrossRef

  7. 7
    Elisa Greggio, Mark R Cookson, Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions, ASN NEURO, 2009, 1, 1, 13

    CrossRef

  8. 8
    Udhaya Kumari, E. K. Tan, LRRK2 in Parkinson’s disease: genetic and clinical studies from patients, FEBS Journal, 2009, 276, 22